Lexicon Drug Patent Portfolio
Lexicon owns 1 orange book drug protected by 3 US patents Given below is the list of Lexicon's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8217156 | Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use | 07 Oct, 2030 | Active |
| US8476413 | Sulfanyl-tetrahydropyran-based compounds and methods of their use | 29 May, 2028 | Active |
| US7781577 | Inhibitors of sodium glucose co-transporter 2 and methods of their use | 04 May, 2028 | Active |
Latest Legal Activities on Lexicon's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lexicon.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 07 Feb, 2024 | US7781577 |
| Second letter to regulating agency to determine regulatory review period | 07 Feb, 2024 | US8217156 |
| Letter from FDA or Dept of Agriculture re PTE application | 30 Jan, 2024 | US8217156 |
| Letter from FDA or Dept of Agriculture re PTE application | 30 Jan, 2024 | US7781577 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 10 Jan, 2024 | US8217156 |
| Initial letter Re: PTE Application to regulating agency | 08 Aug, 2023 | US7781577 |
| Initial letter Re: PTE Application to regulating agency | 08 Aug, 2023 | US8217156 |
|
Electronic Review
Critical
| 25 Jul, 2023 | US8217156 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 25 Jul, 2023 | US8217156 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 25 Jul, 2023 | US7781577 |
|
Email Notification
Critical
| 25 Jul, 2023 | US7781577 |
|
Email Notification
Critical
| 25 Jul, 2023 | US8217156 |
|
Electronic Review
Critical
| 25 Jul, 2023 | US7781577 |
| Post Issue Communication - Certificate of Correction | 21 Jul, 2023 | US8217156 |
| Patent Term Extension Application under 35 USC 156 Filed | 20 Jul, 2023 | US8217156 |
Lexicon's Family Patents
Lexicon Drug List
Given below is the complete list of Lexicon's drugs and the patents protecting them.
1. Inpefa
Inpefa is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8217156 | Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use |
07 Oct, 2030
(4 years from now)
| Active |
| US8476413 | Sulfanyl-tetrahydropyran-based compounds and methods of their use |
29 May, 2028
(2 years from now)
| Active |
| US7781577 | Inhibitors of sodium glucose co-transporter 2 and methods of their use |
04 May, 2028
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Inpefa's drug page